Cerapedics Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- Cerapedics's estimated revenue is currently $8.4M per year.
- Cerapedics received $22.0M in venture funding in July 2018.
- Cerapedics's estimated revenue per employee is $144310
- Cerapedics's total funding is $112.3M.
- Cerapedics has 58 Employees.
- Cerapedics grew their employee count by 38% last year.
- Cerapedics currently has 1 job openings.
|Katie Davis||Director of Research and Development|
|Rick Preusse||Director of Education and Training|
|Nitin Chawla||Director of Marketing, US|
|Mark Hegerman||Area Director|
|Andrew Barnes||Vice President, US Sales|
|Jerome Connor||VP Research/Development|
|John Limpic||Area Sales Director SouthWest|
|Tommy Vollmar||Vice President of Marketing, Medical Education, & Healthcare Economics|
|Roger White||VP Clinical & Regulatory Affairs|
What Is Cerapedics?
Cerapedics is an advanced orthobiologics company focused on developing its proprietary biomimetic small peptide molecule (P-15) for commercialization in spinal applications. i-FACTOR Peptide Enhanced Bone Graft (P-15/ABM) is only the 2nd FDA PMA Approve bone graft on the market, and it has shown statistical superiority to local autograft through an IDE trial on single-level ACDFs in overall clinical success at one year. i-FACTOR is the only biologic bone graft in orthopedics that incorporates a small peptide as an attachment factor to stimulate the natural bone healing process. This novel mechanism of action (Attract, Attach, Activate) is designed to support safer and more predictable bone formation compared to other commercially available bone growth factors.keywords:Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Mile High Labs||$26.2M||181||596%||$100M|
|Front Range Bio...||$7.3M||50||67%|
WESTMINSTER, Colo., July 8, 2019 /PRNewswire/ -- Cerapedics, a private ortho-biologics company, today announced the expansion of the ...
WESTMINSTER, Colo., March 6, 2019 /PRNewswire/ -- Cerapedics, a privately-held orthobiologics company, today announced that the ...
Cerapedics, a private ortho-biologics company, plans an expansion of the company's headquarters located in metro Denver, Colorado.
|2012-12-13||$19.0M||C||MedImmune Ventures, CVF LLC||Article|
Cerapedics Executive Hires
|2013-05-17||Glen A. Kashuba||CEO||Article|